BioSim Innovations

Name

BioSim Innovations

Legal name

BioSim Innovations

Website

https://biosiminnovations.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Preclinical Contract Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Cell-Based & Potency Assays (Bioassays) (HLAGADAH)

Keywords

• Preclinical research services
• Medical device testing
• Translational research
• Contract research organization
• Device validation studies

Headquarters

HQ city

Brooklyn Park

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Preclinical Research Services: Contract research services providing preclinical testing and study design for medical device and therapy developers. Services are likely project-based or contracted engagements where BioSim designs and executes studies to answer specific questions about device safety and efficacy. The company leverages expert teams and cutting-edge technologies to deliver comprehensive research data supporting regulatory submissions and clinical progression.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

BioSim Innovations is a preclinical contract research organization that provides medical device model development, device testing, and laboratory services to medical device and biotech companies. The offering is centered on a "Wheel of Services" portfolio covering Knowledge Driven Research, Synergistic Study Design, Research With Insight, and Cadavers + Imaging, with project-based engagements that design and execute preclinical studies to support device safety, efficacy, and regulatory submissions.

Product overview

BioSim Innovations offers a unified preclinical research services platform called the Wheel of Services, designed to bridge discovery and clinical application for medical devices and therapies. The portfolio includes Knowledge Driven Research (question identification and model design), Synergistic Study Design (strategic planning for regulatory pathways), Research With Insight (expert consultation and technology integration), and Cadavers + Imaging services. Together, these modules support translational preclinical research with a focus on accelerating development timelines and maximizing data utility for life-saving device advancement.

Differentiator

Problem solved

Functional benefit

Products and services

• Wheel of Services Structured portfolio of preclinical research services organized around synergistic study design for medical device and biotech clients, spanning Knowledge Driven Research, Synergistic Study Design, Research With Insight, and Cadavers + Imaging. Aimed at medical device and therapy developers needing translational preclinical support to bridge discovery and clinical application.
• Knowledge Driven Research Preclinical research service focused on identifying what needs to be learned about each device or therapy, selecting the optimal model to answer the question, and designing clinically relevant models when standard models are unavailable. Intended for medical device and therapy developers requiring custom preclinical study design.
• Synergistic Study Design Strategic study planning service that considers the regulatory and clinical end goals from the beginning, enabling the most effective path to market by integrating multiple scientific disciplines and data streams. Targeted at medical device and biotech developers needing cohesive, multi-disciplinary preclinical study programs.
• Research With Insight Expert consultation service that brings together capabilities, experts, and cutting-edge technologies and ideas in one location, providing a multidisciplinary team prepared to push device design forward. Intended for medical device developers needing expert-driven preclinical insight.
• Cadavers + Imaging Preclinical anatomical and imaging services supporting medical device testing and validation through cadaver-based studies. Targeted at medical device developers needing anatomical and imaging-based preclinical evidence for device performance and safety.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Recent moves3 records

Direct peers

• Toxikon: Toxikon is a preclinical contract research organization specializing in medical device and pharmaceutical safety testing. It directly competes with BioSim on device biocompatibility, preclinical toxicology, and translational safety studies.
• Med Institute: Med Institute is a medical device-focused preclinical and clinical research organization providing testing, study design, and regulatory support. It is a direct peer in the medical device preclinical CRO space, comparable in size and focus to BioSim.
• NAMSA: NAMSA is the largest pure-play medical device-focused preclinical and clinical CRO, offering testing, regulatory, and consulting services. It directly competes with BioSim in medical device preclinical studies, biological safety, and translational research.
• CBSET: CBSET is a preclinical CRO specializing in medical devices, combination products, and novel therapies with capabilities in interventional procedures, imaging, and GLP-compliant studies — closely overlapping BioSim's medical device preclinical niche.

Broad incumbents

• ICON plc: ICON is a large global CRO with preclinical and clinical capabilities across multiple therapeutic areas. It is a broad incumbent that competes with smaller preclinical specialists like BioSim for outsourced device and biotech research work.
• IQVIA: IQVIA is a global life sciences services firm providing R&D, clinical, and real-world evidence services. While stronger in clinical than preclinical, it is an incumbent option for medical device sponsors evaluating outsourced research partners.
• Labcorp (Covance Drug Development): Labcorp, through Covance, offers preclinical and central laboratory services supporting device and pharma sponsors. It competes broadly for outsourced research and lab services, though its focus skews to pharma/clinical rather than device preclinical.
• Charles River Laboratories: Charles River is a global, multi-segment preclinical CRO with extensive safety assessment, discovery, and research models services. It competes with BioSim for biomedical preclinical work but is a broad incumbent rather than a device specialist.
• WuXi AppTec: WuXi AppTec is a large global CRO/CDMO offering preclinical and clinical research services across biologics, small molecules, and devices. It overlaps BioSim on preclinical study design and lab services but at vastly greater scale and breadth.

Emerging players

• MRIGlobal: MRIGlobal is an independent, nonprofit applied research organization offering laboratory and preclinical research services to government and commercial clients. It overlaps BioSim on translational preclinical and lab capabilities, particularly in the US Midwest.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks7 records

Key highlights5 records

Customer concentration

• Xx.com/_BioSim
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/biosim-innovations

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioSim Innovations